Clinical Trial Update: A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC [Phase 1, Phase 2]

View source ↗

Summary

Recruiting Phase 1/2 clinical trial at Fudan University evaluating neo-adjuvant therapy for breast cancer guided by a molecular pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING